Authors' reply to letter by Martinod et al. on rationale for using lenvatinib as an urgent initial therapy in thyroid cancer with remarkable laryngotracheal invasion. - Katoh H; Okamoto R; Ozawa Y; Tokito T; Kikuchi M; Sangai T (European thyroid journal, 2025)